Microdose Tirzepatide Program

Compounded GLP-1 Therapy (Microdose Tirzepatide)

For patients who want to begin more gradually, this program offers a lower starting strength of the same dual-action GLP-1/GIP compounded injectable, with dosing set and adjusted by a licensed provider based on tolerance and goals following an online medical evaluation.

Gentler starting dose for patients who want a lower-strength entry point.

Provider-guided titration schedule as you build tolerance.

Same monthly, pharmacy-direct delivery as our standard programs.

Compounded medications are not FDA-approved. The FDA does not review compounded products for safety, effectiveness, or quality.

Former Customer

“I’ve noticed a real difference in my appetite and energy, and it’s reassuring to have provider oversight along the way.”

How It Works

Complete a private online intake, get reviewed by a licensed provider, and receive your personalized microdose tirzepatide plan — shipped monthly from a U.S.-licensed pharmacy.

Frequently Asked Questions

  • No. Compounded tirzepatide is not FDA-approved, and the FDA does not review compounded products for safety, effectiveness, or quality. It’s prepared by a licensed pharmacy and prescribed only after an online medical consultation.

  • After you complete a short online intake, a licensed provider reviews your health history and goals to determine whether this program is clinically appropriate for you.

  • Yes. Your subscription can be canceled at any time — there’s no long-term commitment required.

  • A licensed provider reviews your intake, typically within 1-2 business days. If appropriate, they’ll prescribe your personalized plan, which ships monthly from a U.S.-licensed pharmacy. If it’s not a fit, you’ll be notified and won’t be charged.

  • Most compounded peptide programs are not billed to insurance. Your intake and provider consultation costs are outlined before you begin, with transparent, all-inclusive pricing.